---
title: "Paxlovid (nirmatrelvir; ritonavir), all indications: Drug interactions questions"
description: "Drug interactions questions on Paxlovid (nirmatrelvir; ritonavir) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What drug interactions does Paxlovid have? Which medications should not be taken with Paxlovid? How should drug interactions be checked before prescribing Paxlovid? In Pfizer's 2019 claims analysis, how many top-100 drugs interact with Paxlovid? 28 further questions follow. 32 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/paxlovid/drug-interactions"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Paxlovid (nirmatrelvir; ritonavir), all indications: Drug interactions questions

Manufacturer: Pfizer Inc  
Prescribing information: [Paxlovid](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599)  
Indication pages: [COVID-19](https://www.evicenter.com/medical-information/paxlovid--covid-19)

## Drug interactions

<a id="paxlovid-drug-interactions"></a>

### What drug interactions does Paxlovid have?

> “PAXLOVID (nirmatrelvir co-packaged with ritonavir) is a strong inhibitor of CYP3A, and an inhibitor of CYP2D6, P-gp and OATP1B1. Co-administration of PAXLOVID with drugs that are primarily metabolized by CYP3A and CYP2D6 or are transported by P-gp or OATP1B1 may result in increased plasma concentrations of such drugs and increase the risk of adverse events. Co-administration of PAXLOVID with drugs highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated [see Contraindications (4) and Drug Interactions (7.3) Table 2]. Co-administration with other CYP3A substrates may require a dose adjustment or additional monitoring as shown in Table 2.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=PAXLOVID%20%28nirmatrelvir%20co%2Dpackaged%20with%20ritonavir%29,as%20shown%20in%20Table%202.)

> “Nirmatrelvir and ritonavir are CYP3A substrates; therefore, drugs that induce CYP3A may decrease nirmatrelvir and ritonavir plasma concentrations and reduce PAXLOVID therapeutic effect [see Contraindications (4) and Drug Interactions (7.3) Table 2].”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Nirmatrelvir%20and%20ritonavir%20are%20CYP3A,Drug%20Interactions%20%287.3%29%20Table%202%5D.)

> “Severe, life-threatening, and/or fatal adverse reactions due to drug interactions have been reported in patients treated with PAXLOVID. The most commonly reported concomitant medications resulting in serious adverse reactions were calcineurin inhibitors (e.g., tacrolimus, cyclosporine), followed by calcium channel blockers.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Severe%2C%20life%2Dthreatening%2C%20and%2For%20fatal%20adverse,followed%20by%20calcium%20channel%20blockers.)

<a id="paxlovid-contraindicated-drugs"></a>

### Which medications should not be taken with Paxlovid?

> “Drugs that are primarily metabolized by CYP3A for which elevated concentrations are associated with serious and/or life-threatening reactions [see Drug Interactions (7.3)]:
> •
> Alpha 1-adrenoreceptor antagonist: alfuzosin
> •
> Antianginal: ranolazine
> •
> Antiarrhythmic: amiodarone, dronedarone, flecainide, propafenone, quinidine
> •
> Anti-gout: colchicine (in patients with renal and/or hepatic impairment [see Table 2, Drug Interactions (7.3)])
> •
> Antipsychotics: lurasidone, pimozide
> •
> Benign prostatic hyperplasia agents: silodosin
> •
> Cardiovascular agents: eplerenone, ivabradine
> •
> Ergot derivatives: dihydroergotamine, ergotamine, methylergonovine
> •
> HMG-CoA reductase inhibitors: lovastatin, simvastatin (these drugs can be temporarily discontinued to allow PAXLOVID use [see Table 2, Drug Interactions (7.3)])
> •
> Immunosuppressants: voclosporin
> •
> Microsomal triglyceride transfer protein inhibitor: lomitapide
> •
> Migraine medications: eletriptan, ubrogepant
> •
> Mineralocorticoid receptor antagonists: finerenone
> •
> Non-opioid analgesic (selective blocker of Nav1.8 sodium channels): suzetrigine
> •
> Opioid antagonists: naloxegol
> •
> PDE5 inhibitor: sildenafil (Revatio®) when used for pulmonary arterial hypertension (PAH)
> •
> Sedative/hypnotics: triazolam, oral midazolam
> •
> Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin
> •
> Vasopressin receptor antagonists: tolvaptan
> ➢
> Drugs that are strong CYP3A inducers where significantly reduced nirmatrelvir or ritonavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance. PAXLOVID cannot be started immediately after discontinuation of any of the following medications due to the delayed offset of the recently discontinued CYP3A inducer [see Drug Interactions (7.3)]:
> •
> Anticancer drugs: apalutamide, enzalutamide
> •
> Anticonvulsant: carbamazepine, phenobarbital, primidone, phenytoin
> •
> Antimycobacterials: rifampin, rifapentine
> •
> Cystic fibrosis transmembrane conductance regulator potentiators: lumacaftor/ivacaftor
> •
> Herbal products: St. John's Wort (hypericum perforatum)”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drugs%20that%20are%20primarily%20metabolized%20by%20CYP3A%20for,St.%20John%27s%20Wort%20%28hypericum%20perforatum%29)

> “Drugs listed in this section are a guide and not considered a comprehensive list of all drugs that may be contraindicated with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drugs%20listed%20in%20this%20section,may%20be%20contraindicated%20with%20PAXLOVID.)

<a id="paxlovid-before-prescribing"></a>

### How should drug interactions be checked before prescribing Paxlovid?

> “Prior to prescribing PAXLOVID, review all medications taken by the patient to assess potential drug-drug interactions and determine if concomitant medications require a dose adjustment, interruption, and/or additional monitoring (e.g., calcineurin inhibitors) [see Contraindications (4) and Drug Interactions (7)]. See Table 2 for clinically significant drug interactions, including contraindicated drugs. Drugs listed in Table 2 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Prior%20to%20prescribing%20PAXLOVID%2C%20review,that%20may%20interact%20with%20PAXLOVID.)

> “Inform patients that PAXLOVID may interact with certain drugs and is contraindicated for use with certain drugs; therefore, advise patients to report to their healthcare provider the use of any prescription, non-prescription medication, or herbal products [see Boxed Warning, Contraindications (4), Warnings and Precautions (5.1), and Drug Interactions (7)].”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Inform%20patients%20that%20PAXLOVID%20may,%285.1%29%2C%20and%20Drug%20Interactions%20%287%29%5D.)

> “Pfizer Medical Information’s Drug Interaction Checker
>
> Search concomitant medications to check for potential drug interactions”

Source: [PAXLOVID: Viral Rebound, captured 2026-11-13](https://paxlovid.pfizerpro.com/safety/viral-rebound#:~:text=Pfizer%20Medical%20Information%E2%80%99s%20Drug%20Interaction,check%20for%20potential%20drug%20interactions)

Note: The last passage names a drug interaction checker that Pfizer Medical Information provides, linked from the Paxlovid HCP site.

<a id="paxlovid-top-100-drugs"></a>

### In Pfizer's 2019 claims analysis, how many top-100 drugs interact with Paxlovid?

> “In a retrospective analysis* conducted by Pfizer, 70 of the top 100 drugs identified by insurance claims within the Optum database as the most prescribed to US patients at high risk for severe COVID-19 disease were not expected to interact with PAXLOVID.<sup>†‡</sup>”

Source: [PAXLOVID: Drug Interactions, captured 2026-11-13](https://paxlovid.pfizerpro.com/safety/drug-interactions#:~:text=In%20a%20retrospective%20analysis%2A%20conducted,not%20expected%20to%20interact%20with)

> “*This descriptive retrospective analysis used the Optum Clinformatics Data Mart (CDM) to evaluate prescription medication use among adults at high risk of progression to severe COVID-19. The top 100 drugs were identified based on total counts associated with drugs prescribed to high-risk patients (ie, >1 medical condition associated with an increased risk of severe COVID-19) who were continuously enrolled in the database throughout 2019 and had >1 prescription claim.<sup>2</sup>
> †Among the 30 drugs that are expected to interact with PAXLOVID, the drug classes containing drugs expected to result in a clinically relevant drug interaction include corticosteroids, narcotic analgesics, sedatives/hypnotics, HMG-CoA reductase inhibitors (statins), calcium channel blockers, alpha 1-adrenoreceptor antagonists, antidepressants, antiplatelet agents/anticoagulants, antibiotics, antifungals, anticonvulsants, and hormonal contraceptives. One drug of the top 100 observed, simvastatin, is contraindicated.<sup>2</sup>
> ‡The PAXLOVID Prescribing Information, in which additional pharmacokinetic data were incorporated demonstrating no relevant clinical interactions with rosuvastatin, was updated in September 2024. Therefore, the number in this 2023 analysis may be updated to "71 of the top 100 drugs," instead of 70, to best reflect this change.<sup>1,2</sup>”

Source: [PAXLOVID: Drug Interactions, captured 2026-11-13](https://paxlovid.pfizerpro.com/safety/drug-interactions#:~:text=%2AThis%20descriptive%20retrospective%20analysis%20used,70%2C%20to%20best%20reflect%20this)

> “Drugs listed in Table 2 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=and%20Precautions%20%285.1%29%5D.-,Drugs%20listed%20in%20Table%202%20are%20a%20guide%20and%20not,that%20may%20interact%20with%20PAXLOVID.)

Note: This is a Pfizer analysis of 2019 prescription claims (Gerhart J, et al. AAPS J. 2023), presented on the Drug Interactions page of the Paxlovid HCP site.

<a id="paxlovid-statins"></a>

### Can Paxlovid be taken with statins like simvastatin or atorvastatin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “HMG-CoA reductase inhibitors
>
>
>
> lovastatin,
> simvastatin
>
>
>
> ↑ lovastatin
> ↑ simvastatin
>
>
>
> Co-administration contraindicated due to potential for myopathy including rhabdomyolysis [see Contraindications (4)].
>
> If treatment with PAXLOVID is considered medically necessary, discontinue use of lovastatin and simvastatin at least 12 hours prior to initiation of PAXLOVID, during the 5 days of PAXLOVID treatment, and for 5 days after completing PAXLOVID.
>
>
>
>
> HMG-CoA reductase inhibitors
>
>
>
> atorvastatin
>
>
>
> ↑ atorvastatin
>
>
>
>
> Consider temporary discontinuation of atorvastatin during treatment with PAXLOVID. Atorvastatin does not need to be withheld prior to or after completing PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=%5Bsee%20Contraindications%20%284%29%5D.-,HMG%2DCoA%20reductase%20inhibitors,to%20or%20after%20completing%20PAXLOVID.)

<a id="paxlovid-rosuvastatin"></a>

### Does Paxlovid interact with rosuvastatin?

> “Table 6: Effect of Nirmatrelvir/Ritonavir on Pharmacokinetics of Other Drugs
> Co-administered Drug	Dose (Schedule)	N	Percent Ratio of Test/Reference of Geometric Means (90% CI);
> No Effect=100
> Co-administered Drug	Nirmatrelvir/ Ritonavir	Cmax	AUCinf”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Table%206%3A%20Effect%20of%20Nirmatrelvir%2FRitonavir,AUCinf)

> “Rosuvastatin*
>
>
>
> 10 mg
>
> (1 dose)
>
>
>
> 300 mg/100 mg twice daily
> (3 doses)
>
>
>
> 12
>
>
>
> 212.44
>
> (174.31, 258.90)
>
>
>
> 131.18
>
> (115.89, 148.48)”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Rosuvastatin%2A,%28115.89%2C%20148.48%29)

> “For rosuvastatin, Test=nirmatrelvir/ritonavir plus rosuvastatin, Reference=Rosuvastatin. Rosuvastatin is an index substrate for OATP1B1.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=For%20rosuvastatin%2C%20Test%3Dnirmatrelvir%2Fritonavir%20plus%20rosuvastatin%2C,an%20index%20substrate%20for%20OATP1B1.)

> “‡The PAXLOVID Prescribing Information, in which additional pharmacokinetic data were incorporated demonstrating no relevant clinical interactions with rosuvastatin, was updated in September 2024.”

Source: [PAXLOVID: Drug Interactions, captured 2026-11-13](https://paxlovid.pfizerpro.com/safety/drug-interactions#:~:text=%E2%80%A1The%20PAXLOVID%20Prescribing%20Information%2C%20in,was%20updated%20in%20September%202024.)

Note: Table 6 values are percent ratios of rosuvastatin exposure with and without nirmatrelvir/ritonavir (100 = no effect). Rosuvastatin is not listed in Table 2 of the Prescribing Information. The statement that the data show no relevant clinical interaction is from a footnote on the Drug Interactions page of the Paxlovid HCP site.

<a id="paxlovid-calcineurin-inhibitors"></a>

### Can Paxlovid be taken with tacrolimus or cyclosporine?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Immunosuppressants
>
>
>
> calcineurin inhibitors:
> cyclosporine,
> tacrolimus
>
>
>
>
> ↑ cyclosporine
> ↑ tacrolimus
>
>
>
> Avoid concomitant use of calcineurin inhibitors with PAXLOVID when close monitoring of immunosuppressant concentrations is not feasible. If co-administered, dose adjustment of the immunosuppressant and close and regular monitoring for immunosuppressant concentrations and adverse reactions are recommended during and after treatment with PAXLOVID. Obtain expert consultation to appropriately manage the complexity of this co-administration [see Warnings and Precautions (5.1)].
>
>
>
>
> mTOR inhibitors:
> everolimus,
> sirolimus
>
>
>
>
> ↑ everolimus
> ↑ sirolimus
>
>
>
>
> Avoid concomitant use of everolimus and sirolimus and PAXLOVID.
>
> Refer to the individual immunosuppressant prescribing information and latest guidelines for further information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=%5Bsee%20Contraindications%20%284%29%5D.-,Immunosuppressants,latest%20guidelines%20for%20further%20information.)

> “The most commonly reported concomitant medications resulting in serious adverse reactions were calcineurin inhibitors (e.g., tacrolimus, cyclosporine), followed by calcium channel blockers.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=The%20most%20commonly%20reported%20concomitant,followed%20by%20calcium%20channel%20blockers.)

<a id="paxlovid-blood-thinners"></a>

### Can Paxlovid be taken with blood thinners like apixaban or warfarin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Anticoagulants
>
>
>
> warfarin
>
>
>
> ↑↓ warfarin
>
>
>
> Closely monitor international normalized ratio (INR) if co-administration with warfarin is necessary.
>
>
>
>
> rivaroxaban
>
>
>
> ↑ rivaroxaban
>
>
>
> Increased bleeding risk with rivaroxaban. Avoid concomitant use.
>
>
>
>
> dabigatran*
>
>
>
> ↑ dabigatran
>
>
>
> Increased bleeding risk with dabigatran. Depending on dabigatran indication and renal function, reduce dose of dabigatran or avoid concomitant use. Refer to the dabigatran prescribing information for further information.
>
>
>
>
> apixaban
>
>
>
> ↑ apixaban
>
>
>
> Combined P-gp and strong CYP3A inhibitors increase blood levels of apixaban and increase the risk of bleeding. Dosing recommendations for co-administration of apixaban with PAXLOVID depend on the apixaban dose. Refer to the apixaban prescribing information for more information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Anticoagulants,prescribing%20information%20for%20more%20information.)

> “*
> See Pharmacokinetics, Clinical Drug Interaction Studies (12.3).”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=See%20Pharmacokinetics%2C%20Clinical%20Drug%20Interaction%20Studies%20%2812.3%29.)

<a id="paxlovid-antiplatelets"></a>

### Can Paxlovid be taken with clopidogrel or ticagrelor?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Cardiovascular agents
>
>
>
> aliskiren,
> ticagrelor,
> vorapaxar
>
> clopidogrel
>
>
>
> ↑ aliskiren
> ↑ ticagrelor
> ↑ vorapaxar
>
> ↓ clopidogrel active metabolite
>
>
>
> Avoid concomitant use with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=%5Bsee%20Contraindications%20%284%29%5D.-,Cardiovascular%20agents,Avoid%20concomitant%20use%20with%20PAXLOVID.)

<a id="paxlovid-calcium-channel-blockers"></a>

### Can Paxlovid be taken with amlodipine or other calcium channel blockers?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Calcium channel blockers
>
>
>
> amlodipine,
> diltiazem,
> felodipine,
> nicardipine,
> nifedipine,
> verapamil
>
>
>
> ↑ calcium channel blocker
>
>
>
> Caution is warranted and clinical monitoring of patients is recommended. A dose decrease may be needed for these drugs when co-administered with PAXLOVID.
>
> If co-administered, refer to the individual product prescribing information for calcium channel blocker for further information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=%5Bsee%20Contraindications%20%284%29%5D.-,Calcium%20channel%20blockers,channel%20blocker%20for%20further%20information.)

<a id="paxlovid-antiarrhythmics"></a>

### Can Paxlovid be taken with amiodarone or other antiarrhythmics?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Antiarrhythmics
>
>
>
> amiodarone,
> dronedarone,
> flecainide,
> propafenone,
> quinidine
>
>
>
> ↑ antiarrhythmic
>
>
>
> Co-administration contraindicated due to potential for cardiac arrhythmias [see Contraindications (4)].
>
>
>
>
> Antiarrhythmics
>
>
>
> lidocaine (systemic),
> disopyramide
>
>
>
> ↑ antiarrhythmic
>
>
>
> Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics if available.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Antiarrhythmics,recommended%20for%20antiarrhythmics%20if%20available.)

<a id="paxlovid-digoxin"></a>

### Can Paxlovid be taken with digoxin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Cardiac glycosides
>
>
>
> digoxin
>
>
>
> ↑ digoxin
>
>
>
> Caution should be exercised when co-administering PAXLOVID with digoxin, with appropriate monitoring of serum digoxin levels.
>
> Refer to the digoxin prescribing information for further information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Cardiac%20glycosides,prescribing%20information%20for%20further%20information.)

<a id="paxlovid-corticosteroids"></a>

### Can Paxlovid be taken with steroids like dexamethasone or inhaled fluticasone?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Corticosteroids primarily metabolized by CYP3A
>
>
>
> betamethasone,
> budesonide,
> ciclesonide,
> dexamethasone,
> fluticasone,
> methylprednisolone,
> mometasone,
> triamcinolone
>
>
>
> ↑ corticosteroid
>
>
>
> Co-administration with corticosteroids (all routes of administration) of which exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing’s syndrome and adrenal suppression. However, the risk of Cushing’s syndrome and adrenal suppression associated with short-term use of a strong CYP3A inhibitor is low.
>
> Alternative corticosteroids including beclomethasone, prednisone, and prednisolone should be considered.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Corticosteroids%20primarily%20metabolized%20by%20CYP3A,and%20prednisolone%20should%20be%20considered.)

<a id="paxlovid-salmeterol"></a>

### Can Paxlovid be taken with salmeterol inhalers?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Long-acting beta-adrenoceptor agonist
>
>
>
> salmeterol
>
>
>
> ↑ salmeterol
>
>
>
> Avoid concomitant use with PAXLOVID. The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations, and sinus tachycardia.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Long%2Dacting%20beta%2Dadrenoceptor%20agonist,prolongation%2C%20palpitations%2C%20and%20sinus%20tachycardia.)

<a id="paxlovid-opioids"></a>

### Can Paxlovid be taken with opioids like oxycodone, fentanyl, or methadone?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Narcotic analgesics
>
>
>
> fentanyl,
> hydrocodone,
> oxycodone,
> meperidine
>
>
>
> ↑ fentanyl
> ↑ hydrocodone
> ↑ oxycodone
> ↑ meperidine
>
>
>
> Careful monitoring of therapeutic and adverse effects (including potentially fatal respiratory depression) is recommended when fentanyl, hydrocodone, oxycodone, or meperidine is concomitantly administered with PAXLOVID. If concomitant use with PAXLOVID is necessary, consider a dosage reduction of the narcotic analgesic and monitor patients closely at frequent intervals. Refer to the individual product prescribing information for more information.
>
>
>
>
> methadone
>
>
>
> ↓ methadone
>
>
>
> Monitor methadone-maintained patients closely for evidence of withdrawal effects and adjust the methadone dose accordingly.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Narcotic%20analgesics,adjust%20the%20methadone%20dose%20accordingly.)

<a id="paxlovid-sleep-medicines"></a>

### Can Paxlovid be taken with benzodiazepines or sleep medicines like zolpidem?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Sedative/hypnotics
>
>
>
> triazolam,
> oral midazolam*
>
>
>
> ↑ triazolam
> ↑ midazolam
>
>
>
> Co-administration contraindicated due to potential for extreme sedation and respiratory depression [see Contraindications (4)].
>
>
>
>
> Sedative/hypnotics
>
>
>
> buspirone,
> clorazepate,
> diazepam,
> estazolam,
> flurazepam,
> zolpidem
>
>
>
> ↑ sedative/hypnotic
>
>
>
> A dose decrease may be needed for these drugs when co-administered with PAXLOVID and monitoring for adverse events.
>
>
>
>
> midazolam (administered parenterally)
>
>
>
> ↑ midazolam
>
>
>
> Co-administration of midazolam (parenteral) should be done in a setting which ensures close clinical monitoring and appropriate medical management in case of respiratory depression and/or prolonged sedation. Dosage reduction for midazolam should be considered, especially if more than a single dose of midazolam is administered.
>
> Refer to the midazolam prescribing information for further information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=for%20more%20information.-,Sedative%2Fhypnotics,prescribing%20information%20for%20further%20information.)

> “clonazepam
>
>
>
> ↑ anticonvulsant
>
>
>
> A dose decrease may be needed for clonazepam when co-administered with PAXLOVID and clinical monitoring is recommended.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=clonazepam,and%20clinical%20monitoring%20is%20recommended.)

> “Neuropsychiatric agents
>
>
>
> suvorexant
>
>
>
> ↑ suvorexant
>
>
>
> Avoid concomitant use of suvorexant with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Neuropsychiatric%20agents,use%20of%20suvorexant%20with%20PAXLOVID.)

<a id="paxlovid-antidepressants"></a>

### Does Paxlovid interact with antidepressants like trazodone or bupropion?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Antidepressants
>
>
>
> bupropion
>
>
>
> ↓ bupropion and active metabolite hydroxy-bupropion
>
>
>
> Monitor for an adequate clinical response to bupropion.
>
>
>
>
> trazodone
>
>
>
> ↑ trazodone
>
>
>
> Adverse reactions of nausea, dizziness, hypotension, and syncope have been observed following co-administration of trazodone and ritonavir. A lower dose of trazodone should be considered. Refer to the trazadone prescribing information for further information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Antidepressants,prescribing%20information%20for%20further%20information.)

<a id="paxlovid-antipsychotics"></a>

### Does Paxlovid interact with antipsychotics like quetiapine?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Antipsychotics
>
>
>
> lurasidone,
> pimozide
>
>
>
> ↑ lurasidone
> ↑ pimozide
>
>
>
> Co-administration contraindicated due to serious and/or life-threatening reactions such as cardiac arrhythmias [see Contraindications (4)].
>
>
>
>
> Antipsychotics
>
>
>
> quetiapine
>
>
>
> ↑ quetiapine
>
>
>
> If co-administration is necessary, reduce quetiapine dose and monitor for quetiapine-associated adverse reactions. Refer to the quetiapine prescribing information for recommendations.
>
>
>
>
> clozapine
>
>
>
> ↑ clozapine
>
>
>
> If co-administration is necessary, consider reducing the clozapine dose and monitor for adverse reactions.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=rifabutin%20dose%20reduction.-,Antipsychotics,and%20monitor%20for%20adverse%20reactions.)

> “Neuropsychiatric agents
>
>
>
> suvorexant
>
>
>
> ↑ suvorexant
>
>
>
> Avoid concomitant use of suvorexant with PAXLOVID.
>
>
>
>
> aripiprazole,
> brexpiprazole,
> cariprazine,
> iloperidone,
> lumateperone,
> pimavanserin
>
>
>
> ↑ aripiprazole
> ↑ brexpiprazole
> ↑ cariprazine
> ↑ iloperidone
> ↑ lumateperone
> ↑ pimavanserin
>
>
>
> Dosage adjustment of aripiprazole, brexpiprazole, cariprazine, iloperidone, lumateperone, and pimavanserin is recommended. Refer to the individual product prescribing information for more information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Neuropsychiatric%20agents,prescribing%20information%20for%20more%20information.)

<a id="paxlovid-birth-control"></a>

### Does Paxlovid make birth control pills less effective?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Hormonal contraceptive
>
>
>
> ethinyl estradiol
>
>
>
> ↓ ethinyl estradiol
>
>
>
> An additional, non-hormonal method of contraception should be considered during the 5 days of PAXLOVID treatment and until one menstrual cycle after stopping PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Hormonal%20contraceptive,menstrual%20cycle%20after%20stopping%20PAXLOVID.)

> “Use of ritonavir may reduce the efficacy of combined hormonal contraceptives. Advise patients using combined hormonal contraceptives to use an effective alternative contraceptive method or an additional barrier method of contraception [see Drug Interactions (7.3)].”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Use%20of%20ritonavir%20may%20reduce,contraception%20%5Bsee%20Drug%20Interactions%20%287.3%29%5D.)

<a id="paxlovid-hiv-medicines"></a>

### Can Paxlovid be taken with HIV medicines?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Anti-HIV protease inhibitors
>
>
>
> atazanavir,
> darunavir,
> tipranavir
>
>
>
> ↑ protease inhibitor
>
>
>
> For further information, refer to the respective protease inhibitors' prescribing information.
>
> Patients on ritonavir- or cobicistat-containing HIV regimens should continue their treatment as indicated. Monitor for increased PAXLOVID or protease inhibitor adverse events.
>
>
>
>
> Anti-HIV
>
>
>
> efavirenz,
> maraviroc,
> nevirapine,
> zidovudine,
> bictegravir/
> emtricitabine/
> tenofovir
>
>
>
> ↑ efavirenz
> ↑ maraviroc
> ↑ nevirapine
> ↓ zidovudine
> ↑ bictegravir
> ↔ emtricitabine
> ↑ tenofovir
>
>
>
> For further information, refer to the respective anti-HIV drugs prescribing information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Anti%2DHIV%20protease%20inhibitors,respective%20anti%2DHIV%20drugs%20prescribing%20information.)

> “If you are taking a ritonavir- or cobicistat-containing medicine to treat hepatitis C or HIV-1 infection, you should continue to take your medicine as prescribed by your healthcare provider.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=If%20you%20are%20taking%20a,prescribed%20by%20your%20healthcare%20provider.)

> “Drugs listed in Table 2 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=and%20Precautions%20%285.1%29%5D.-,Drugs%20listed%20in%20Table%202%20are%20a%20guide%20and%20not,that%20may%20interact%20with%20PAXLOVID.)

<a id="paxlovid-ed-medicines"></a>

### Can Paxlovid be taken with sildenafil or tadalafil?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Pulmonary hypertension agents (PDE5 inhibitors)
>
>
>
> sildenafil (Revatio®)
>
>
>
> ↑ sildenafil
>
>
>
> Co-administration of sildenafil with PAXLOVID is contraindicated for use in pulmonary hypertension due to the potential for sildenafil associated adverse events, including visual abnormalities hypotension, prolonged erection, and syncope [see Contraindications (4)].
>
>
>
>
> Pulmonary hypertension agents (PDE5 inhibitors)
>
>
>
> tadalafil (Adcirca®)
>
>
>
> ↑ tadalafil
>
>
>
> Avoid concomitant use of tadalafil with PAXLOVID for pulmonary hypertension.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Pulmonary%20hypertension%20agents%20%28PDE5%20inhibitors%29,with%20PAXLOVID%20for%20pulmonary%20hypertension.)

> “Erectile dysfunction agents (PDE5 inhibitors)
>
>
>
> avanafil
>
>
>
> ↑ avanafil
>
>
>
> Do not use PAXLOVID with avanafil because a safe and effective avanafil dosage regimen has not been established.
>
>
>
>
> sildenafil,
> tadalafil,
> vardenafil
>
>
>
> ↑ sildenafil
> ↑ tadalafil
> ↑ vardenafil
>
>
>
> Dosage adjustment is recommended for use of sildenafil, tadalafil or vardenafil with PAXLOVID when used for erectile dysfunction. Refer to the individual product prescribing information for more information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Erectile%20dysfunction%20agents%20%28PDE5%20inhibitors%29,prescribing%20information%20for%20more%20information.)

<a id="paxlovid-colchicine"></a>

### Can Paxlovid be taken with colchicine?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Anti-gout
>
>
>
> colchicine
>
>
>
> ↑ colchicine
>
>
>
> Co-administration contraindicated due to potential for serious and/or life-threatening reactions in patients with renal and/or hepatic impairment [see Contraindications (4)].”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=is%20not%20needed.-,Anti%2Dgout,hepatic%20impairment%20%5Bsee%20Contraindications%20%284%29%5D.)

<a id="paxlovid-anticonvulsants"></a>

### Can Paxlovid be taken with seizure medicines like carbamazepine or phenytoin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Anticonvulsants
>
>
>
> carbamazepine*,
> phenobarbital,
> primidone,
> phenytoin
>
>
>
> ↓ nirmatrelvir/ritonavir
>
>
>
> Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4)].
>
>
>
>
> Anticonvulsants
>
>
>
> clonazepam
>
>
>
> ↑ anticonvulsant
>
>
>
> A dose decrease may be needed for clonazepam when co-administered with PAXLOVID and clinical monitoring is recommended.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Anticonvulsants,and%20clinical%20monitoring%20is%20recommended.)

> “PAXLOVID cannot be started immediately after discontinuation of any of the following medications due to the delayed offset of the recently discontinued CYP3A inducer [see Drug Interactions (7.3)]:
> •
> Anticancer drugs: apalutamide, enzalutamide
> •
> Anticonvulsant: carbamazepine, phenobarbital, primidone, phenytoin
> •
> Antimycobacterials: rifampin, rifapentine
> •
> Cystic fibrosis transmembrane conductance regulator potentiators: lumacaftor/ivacaftor
> •
> Herbal products: St. John's Wort (hypericum perforatum)”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=PAXLOVID%20cannot%20be%20started%20immediately,St.%20John%27s%20Wort%20%28hypericum%20perforatum%29)

<a id="paxlovid-st-johns-wort"></a>

### Can Paxlovid be taken with St. John's Wort or herbal supplements?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Herbal products
>
>
>
> St. John's Wort (hypericum perforatum)
>
>
>
> ↓ nirmatrelvir/ritonavir
>
>
>
> Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4)].”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=with%20concomitant%20use.-,Herbal%20products,possible%20resistance%20%5Bsee%20Contraindications%20%284%29%5D.)

> “Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Tell%20your%20healthcare%20provider%20about%20all%20the,medicines%2C%20vitamins%2C%20and%20herbal%20supplements.)

<a id="paxlovid-hepatitis-c-medicines"></a>

### Can Paxlovid be taken with hepatitis C medicines?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Hepatitis C direct acting antivirals
>
>
>
> elbasvir/grazoprevir
>
>
>
> ↑ antiviral
>
>
>
> Increased grazoprevir concentrations can result in alanine transaminase (ALT) elevations.
>
>
>
>
> glecaprevir/pibrentasvir
>
>
>
> Avoid concomitant use of glecaprevir/pibrentasvir with PAXLOVID.
>
>
>
>
> ombitasvir/paritaprevir/ritonavir and dasabuvir
>
>
>
> Refer to the ombitasvir/paritaprevir/ritonavir and dasabuvir label for further information.
>
>
>
>
> sofosbuvir/velpatasvir/voxilaprevir
>
>
>
> Refer to the sofosbuvir/velpatasvir/voxilaprevir prescribing information for further information.
> Patients on ritonavir-containing HCV regimens should continue their treatment as indicated. Monitor for increased PAXLOVID or HCV drug adverse events with concomitant use.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Hepatitis%20C%20direct%20acting%20antivirals,adverse%20events%20with%20concomitant%20use.)

> “Drugs listed in Table 2 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=and%20Precautions%20%285.1%29%5D.-,Drugs%20listed%20in%20Table%202%20are%20a%20guide%20and%20not,that%20may%20interact%20with%20PAXLOVID.)

<a id="paxlovid-rifampin"></a>

### Can Paxlovid be taken with rifampin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Antimycobacterial
>
>
>
> rifampin,
> rifapentine
>
>
>
> ↓ nirmatrelvir/ritonavir
>
>
>
> Co-administration contraindicated due to potential loss of virologic response and possible resistance. Alternate antimycobacterial drugs such as rifabutin should be considered [see Contraindications (4)].
>
>
>
>
> Antimycobacterial
>
>
>
> bedaquiline
>
>
>
> ↑ bedaquiline
>
>
>
> Refer to the bedaquiline prescribing information for further information.
>
>
>
>
> rifabutin
>
>
>
> ↑ rifabutin
>
>
>
> Refer to the rifabutin prescribing information for further information on rifabutin dose reduction.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Antimycobacterial,information%20on%20rifabutin%20dose%20reduction.)

<a id="paxlovid-antibiotics-antifungals"></a>

### Does Paxlovid interact with clarithromycin, erythromycin, voriconazole, or itraconazole?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Antifungals
>
>
>
> voriconazole
>
>
>
> ↓ voriconazole
>
>
>
> Avoid concomitant use of voriconazole.
>
>
>
>
> ketoconazole,
> isavuconazonium sulfate,
> itraconazole*
>
>
>
> ↑ ketoconazole
> ↑ isavuconazonium sulfate
> ↑ itraconazole
>
>
>
> Refer to the ketoconazole, isavuconazonium sulfate, and itraconazole prescribing information for further information.
>
>
>
>
> ↑ nirmatrelvir/ritonavir
>
>
>
> A nirmatrelvir/ritonavir dose reduction is not needed.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Antifungals,dose%20reduction%20is%20not%20needed.)

> “Anti-infective
>
>
>
> clarithromycin,
> erythromycin
>
>
>
> ↑ clarithromycin
> ↑ erythromycin
>
>
>
> Refer to the respective prescribing information for anti-infective dose adjustment.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Anti%2Dinfective,information%20for%20anti%2Dinfective%20dose%20adjustment.)

> “Drugs listed in Table 2 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=and%20Precautions%20%285.1%29%5D.-,Drugs%20listed%20in%20Table%202%20are%20a%20guide%20and%20not,that%20may%20interact%20with%20PAXLOVID.)

Note: In the label table, the row with an empty drug cell stating that nirmatrelvir/ritonavir concentrations increase and that a nirmatrelvir/ritonavir dose reduction is not needed follows the ketoconazole, isavuconazonium sulfate, and itraconazole row.

<a id="paxlovid-migraine-medicines"></a>

### Can Paxlovid be taken with migraine medicines like eletriptan or ubrogepant?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Migraine medications
>
>
>
> eletriptan
>
>
>
> ↑ eletriptan
>
>
>
> Co-administration of eletriptan within at least 72 hours of PAXLOVID is contraindicated due to potential for serious adverse reactions including cardiovascular and cerebrovascular events [see Contraindications (4)].
>
>
>
>
> ubrogepant
>
>
>
> ↑ ubrogepant
>
>
>
> Co-administration of ubrogepant with PAXLOVID is contraindicated due to potential for serious adverse reactions [see Contraindications (4)].
>
>
>
>
> Migraine medications
>
>
>
> rimegepant
>
>
>
> ↑ rimegepant
>
>
>
> Avoid concomitant use with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=%5Bsee%20Contraindications%20%284%29%5D.-,Migraine%20medications,Avoid%20concomitant%20use%20with%20PAXLOVID.)

<a id="paxlovid-tamsulosin"></a>

### Can Paxlovid be taken with tamsulosin or alfuzosin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Alpha 1-
> adrenoreceptor antagonist
>
>
>
> alfuzosin
>
>
>
> ↑ alfuzosin
>
>
>
> Co-administration contraindicated due to potential hypotension [see Contraindications (4)].
>
>
>
>
> Alpha 1-
> adrenoreceptor antagonist
>
>
>
> tamsulosin
>
>
>
> ↑ tamsulosin
>
>
>
> Avoid concomitant use with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Interaction%20Studies%20%2812.3%29.-,Alpha%201%2D,Avoid%20concomitant%20use%20with%20PAXLOVID.)

> “Benign prostatic hyperplasia agents
>
>
>
> silodosin
>
>
>
> ↑ silodosin
>
>
>
> Co-administration contraindicated due to potential for postural hypotension [see Contraindications (4)].”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=for%20adverse%20reactions.-,Benign%20prostatic%20hyperplasia%20agents,postural%20hypotension%20%5Bsee%20Contraindications%20%284%29%5D.)

<a id="paxlovid-cancer-medicines"></a>

### Which cancer medicines interact with Paxlovid?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Anticancer drugs
>
>
>
> apalutamide,
>
> enzalutamide
>
>
>
> ↓ nirmatrelvir/ritonavir
>
>
>
> Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4)].
>
>
>
>
> Anticancer drugs
>
>
>
> abemaciclib,
> ceritinib,
> dasatinib,
> encorafenib,
> ibrutinib,
> ivosidenib,
> neratinib,
> nilotinib,
> venetoclax,
> vinblastine,
> vincristine
>
>
>
> ↑ anticancer drugs
>
>
>
> Avoid co-administration of encorafenib or ivosidenib due to potential risk of serious adverse events such as QT interval prolongation. Avoid use of neratinib, venetoclax or ibrutinib.
>
> Co-administration of vincristine and vinblastine may lead to significant hematologic or gastrointestinal side effects.
>
> For further information, refer to the individual product prescribing information for anticancer drug.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=antiarrhythmics%20if%20available.-,Anticancer%20drugs,prescribing%20information%20for%20anticancer%20drug.)

> “Drugs listed in Table 2 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=and%20Precautions%20%285.1%29%5D.-,Drugs%20listed%20in%20Table%202%20are%20a%20guide%20and%20not,that%20may%20interact%20with%20PAXLOVID.)

<a id="paxlovid-saxagliptin"></a>

### Can Paxlovid be taken with saxagliptin?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Dipeptidyl peptidase 4 (DPP4) inhibitors
>
>
>
> saxagliptin
>
>
>
> ↑ saxagliptin
>
>
>
> Dosage adjustment of saxagliptin is recommended. Refer to the saxagliptin prescribing information for more information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Dipeptidyl%20peptidase%204%20%28DPP4%29%20inhibitors,prescribing%20information%20for%20more%20information.)

<a id="paxlovid-jak-inhibitors"></a>

### Can Paxlovid be taken with tofacitinib or upadacitinib (JAK inhibitors)?

> “Drug Class	Drugs within Class	Effect on Concentration	Clinical Comments”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Drug%20Class,Clinical%20Comments)

> “Janus kinase (JAK) inhibitors
>
>
>
> tofacitinib
>
>
>
> ↑ tofacitinib
>
>
>
> Dosage adjustment of tofacitinib is recommended. Refer to the tofacitinib prescribing information for more information.
>
>
>
>
> upadacitinib
>
>
>
> ↑ upadacitinib
>
>
>
> Dosing recommendations for co-administration of upadacitinib with PAXLOVID depends on the upadacitinib indication. Refer to the upadacitinib prescribing information for more information.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Janus%20kinase%20%28JAK%29%20inhibitors,upadacitinib%20prescribing%20information%20for%20more%20information.)

## Related pages
- [Medical information: Paxlovid (nirmatrelvir; ritonavir): All indications](https://www.evicenter.com/medical-information/paxlovid)
- [Indication](https://www.evicenter.com/medical-information/paxlovid/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/paxlovid/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/paxlovid/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/paxlovid/safety)
- [Specific populations](https://www.evicenter.com/medical-information/paxlovid/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/paxlovid/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/paxlovid/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/paxlovid/access-and-coverage)
